How non-profit psychedelic drug development harmonizes with efforts to decriminalize plant medicines and legalize psilocybin therapy for all; and how all support broad-based Portugal style decriminalization This article, recently published in the 2020 MAPS Spring Bulletin, discusses key strategies in motion to mainstream access to psychedelic medicine and therapy in the U.S.. To introduce the topic in the context of the 50th anniversary of Earth Day and the urgent climate change crisis we face, I want to share a quote... Continue Reading